CS

Chitra Sharma

Active Director Director DIN 08884995
DIN 08884995 First appointment Sep 2020 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2020
Shareholding value •••• Premium profile

About Chitra Sharma

Data last updated:

Chitra Sharma is a Director at Cadlay Pharma Private Limited (since 2020). The company operates in Pharma. Cadlay Pharma Private Limited reported revenue of ₹3.27 Cr (FY 2024).

DIN 08884995
Primary Designation Director
Industry Pharma
First Appointment 12 Sep 2020
Oldest Company Age 6 yrs
Largest company Cadlay Pharma Private Limited · ₹3.27 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Cadlay Pharma Private Limited U74999HP2019PTC007708
Director12 Sep 20202019₹3.27 Cr (FY 2024)Active

Board colleagues of Chitra Sharma

Directorship timeline

Open interactive timeline →
Cadlay Pharma Private Limited
Premium access

Shareholding and investment profile for Chitra Sharma

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Chitra Sharma

Chitra Sharma currently holds 1 directorship: Cadlay Pharma Private Limited (Director, since 12 Sep 2020, revenue ₹3.27 Cr (FY 2024)).

Chitra Sharma was first appointed on 12 Sep 2020 as Director at Cadlay Pharma Private Limited.

The current boards of Chitra Sharma's companies include Dilip Kumar Ghosh (Cadlay Pharma Private Limited), Sanjeev Kumar Sharma (Cadlay Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available